ArticleFrontiers in oncology2024

EORTC 2238 "De-Escalate": a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitors.

Guillaume Grisay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.